Dr Silvia Oggero

Silvia Oggero
PhD, personal animal licence, certified phlebotomist

Post Doctoral Research Assistant

Biochemical Pharmacology
William Harvey Research Institute
ORCiD LinkedIn



interest and expertise in all in vitro models which wil mimick inflammation and are crucial in the resolution process in various chronic diseases.


Publications of specific relevance to Predictive in vitro Models


Allen BL, Montague-Cardoso K, Simeoli R, Colas RA, Oggero S, Vilar B, McNaughton PA, Dalli J, Perretti M, Sher E and Malcangio M (2020). Imbalance of proresolving lipid mediators in persistent allodynia dissociated from signs of clinical arthritis. Lippincott, Williams & Wilkins  Pain  10.1097/j.pain.0000000000001908
Piras G, Rattazzi L, Paschalidis N, Oggero S, Berti G, Ono M, Bellia F, D'Addario C, Dell'Osso B, Pariante CM, Perretti M and D'Acquisto F (2020). Immuno-moodulin: A new anxiogenic factor produced by Annexin-A1 transgenic autoimmune-prone T cells. Elsevier  Brain Behavior and Immunity  vol. 87, 689-702. 10.1016/j.bbi.2020.02.015


Oggero S, Austin-Williams S and Norling LV (2019). The contrasting role of extracellular vesicles in vascular inflammation and tissue repair. Frontiers Media  Frontiers in Pharmacology  vol. 10, 10.3389/fphar.2019.01479


Lashin HMS, Nadkarni S, Oggero S, Jones HR, Knight JC, Hinds CJ and Perretti M (2018). Microvesicle Subsets in Sepsis Due to Community Acquired Pneumonia Compared to Faecal Peritonitis. Shock  vol. 49, (4) 393-401. 10.1097/SHK.0000000000000989


Martin L, Horst K, Chiazza F, Oggero S, Collino M, Brandenburg K, Hildebrand F, Marx G, Thiemermann C and Schuerholz T (2016). The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsis. Scientific Reports  vol. 6, 10.1038/srep37277